Delivery Order SPE2DR25D1047-SPE2DR26F24D2
Award Date 12/23/25
Potential Completion Date 1/15/26
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,555.21 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ibrance 125 mg tablets (7-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is scheduled for completion by December 31, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Ibrance 100 mg tablets in a seven-count configuration, with a ceiling value of $8,559.84 and firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of December 19, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued...
- The Defense Logistics Agency awarded a delivery order valued at $8,559.84 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count units) on December 8, 2025, with a completion date of December 30, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $25,679.52 to AmerisourceBergen Drug Corp for 7 tablets of Ibrance 100 mg on October 20, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ibrance is a prescription medication used in oncology treatment, and this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.48 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (quantity 7) on June 2, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Ibrance is a prescription oncology medication used in breast cancer treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a $8,122.48 delivery order to AmerisourceBergen Drug Corp for 7 tablets of Ibrance 100 mg on June 5, 2025, with completion scheduled for June 27, 2025. This competitively awarded, firm fixed-price order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ibrance is a brand-name oncology medication used in cancer treatment, reflecting the pharmaceutical distribution services that...
- The Defense Logistics Agency awarded a delivery order valued at $16,244.96 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count packaging) on September 9, 2025, with a completion date of September 30, 2025. This firm fixed-price delivery order represents a non-competitive set-aside arrangement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $8,118.08 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count) on July 14, 2025, with completion scheduled for August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ibrance is a prescription oncology medication used in cancer treatment, reflecting the critical...
- The Defense Logistics Agency awarded a $8,122.48 delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count units) with a firm fixed price contract type. The award, issued on October 17, 2025, has an ultimate completion date of November 7, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.48 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (quantity 7s) on August 26, 2025, with an ultimate completion date of September 17, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...